These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12861138)

  • 1. Placement of the vaginal 17beta-estradiol tablets in the inner or outer one third of the vagina affects the preferential delivery of 17beta-estradiol toward the uterus or periurethral areas, thereby modifying efficacy and endometrial safety.
    Cicinelli E; Di Naro E; De Ziegler D; Matteo M; Morgese S; Galantino P; Brioschi PA; Schonauer A
    Am J Obstet Gynecol; 2003 Jul; 189(1):55-8. PubMed ID: 12861138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequentially combined hormone replacement therapy reduces impedance to flow within the uterine and central retinal arteries in healthy postmenopausal women.
    van Baal WM; Kenemans P; Stehouwer CD; Peters-Muller ER; van Vugt JM; van der Mooren MJ
    Am J Obstet Gynecol; 1999 Dec; 181(6):1365-73. PubMed ID: 10601914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term treatment with vaginal estradiol tablets--an impact on uterine artery blood flow.
    Dmitrovic R; Klobucar A; Bauman R; Cvitkovic-Kuzmic A; Skalko D; Sonicki Z
    Maturitas; 2005 Apr; 50(4):300-4. PubMed ID: 15780530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal administration of estradiol and norethisterone: effect on the uterus and uterine arteries.
    Cagnacci A; Arangino S; Draetta FP; Angiolucci M; Volpe A; Melis GB
    Menopause; 2000; 7(2):117-22. PubMed ID: 10746894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local estrogen treatment in patients with urogenital symptoms.
    Simunić V; Banović I; Ciglar S; Jeren L; Pavicić Baldani D; Sprem M
    Int J Gynaecol Obstet; 2003 Aug; 82(2):187-97. PubMed ID: 12873780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uterine and vaginal effects of unopposed ultralow-dose transdermal estradiol.
    Johnson SR; Ettinger B; Macer JL; Ensrud KE; Quan J; Grady D
    Obstet Gynecol; 2005 Apr; 105(4):779-87. PubMed ID: 15802405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local oestrogen for vaginal atrophy in postmenopausal women.
    Suckling J; Lethaby A; Kennedy R
    Cochrane Database Syst Rev; 2003; (4):CD001500. PubMed ID: 14583935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen therapy influence on periurethral vessels in postmenopausal incontinent women using Dopplervelocimetry analysis.
    Kobata SA; Girão MJ; Baracat EC; Kajikawa M; Di Bella V; Sartori MG; Jármy-Di Bella ZI
    Maturitas; 2008 Nov; 61(3):243-7. PubMed ID: 18845407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of continuous combined oral estradiol and norethisterone on pulsatility index in internal carotid and uterine arteries in early postmenopausal Taiwanese women---a preliminary study.
    Huang CY; Fu CY; Tseng JY; Yang TS; Chao KC
    Taiwan J Obstet Gynecol; 2009 Mar; 48(1):60-4. PubMed ID: 19346194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood flow changes in the ovarian and uterine arteries during the normal menstrual cycle.
    Tan SL; Zaidi J; Campbell S; Doyle P; Collins W
    Am J Obstet Gynecol; 1996 Sep; 175(3 Pt 1):625-31. PubMed ID: 8828425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial safety of ultra-low-dose Vagifem 10 microg in postmenopausal women with vaginal atrophy.
    Ulrich LS; Naessen T; Elia D; Goldstein JA; Eugster-Hausmann M;
    Climacteric; 2010 Jun; 13(3):228-37. PubMed ID: 20423243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "First uterine pass effect" is observed when estradiol is placed in the upper but not lower third of the vagina.
    Cicinelli E; De Ziegler D; Morgese S; Bulletti C; Luisi D; Schonauer LM
    Fertil Steril; 2004 May; 81(5):1414-6. PubMed ID: 15136116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consistency of Effect with a Low-Dose, Estradiol Vaginal Capsule (TX-004HR): Evaluating Improvement in Vaginal Physiology and Moderate-to-Severe Dyspareunia in Subgroups of Postmenopausal Women.
    Constantine GD; Bouchard C; Pickar JH; Archer DF; Graham S; Bernick B; Mirkin S
    J Womens Health (Larchmt); 2017 Jun; 26(6):616-623. PubMed ID: 28355090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transvaginal color Doppler sonographic assessment of uterus and ovaries in postmenopausal women: the effect of local estrogen treatment.
    Manonai J; Chittacharoen A; Theppisai U
    Eur J Obstet Gynecol Reprod Biol; 2006 Aug; 127(2):222-6. PubMed ID: 16513246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration in the pulsatility index values of the internal carotid and middle cerebral arteries after suspension of postmenopausal hormone replacement therapy: a randomized crossover study.
    Penotti M; Farina M; Castiglioni E; Gaffuri B; Barletta L; Gabrielli L; Vignali M
    Am J Obstet Gynecol; 1996 Sep; 175(3 Pt 1):606-11. PubMed ID: 8828422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance of pelvic arteries and plasma lipids in postmenopausal women: comparative study of tibolone and continuous combined estradiol and norethindrone acetate replacement therapy.
    Dören M; Rübig A; Coelingh Bennink HJ; Holzgreve W
    Am J Obstet Gynecol; 2000 Sep; 183(3):575-82. PubMed ID: 10992176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endometrial thickness and uterine diameter not affected by ultralow doses of 17beta-estradiol in elderly women.
    Naessen T; Rodriguez-Macias K
    Am J Obstet Gynecol; 2002 May; 186(5):944-7. PubMed ID: 12015519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status.
    Gupta P; Ozel B; Stanczyk FZ; Felix JC; Mishell DR
    Menopause; 2008; 15(1):94-7. PubMed ID: 17882008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of uterine artery Doppler in endometrial cancer.
    Flam F; Almström H; Hellström AC; Moberger B
    Acta Oncol; 1995; 34(6):779-82. PubMed ID: 7576745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local estrogen replacement therapy in postmenopausal atrophic vaginitis: efficacy and safety of low dose 17beta-estradiol vaginal tablets.
    Mainini G; Scaffa C; Rotondi M; Messalli EM; Quirino L; Ragucci A
    Clin Exp Obstet Gynecol; 2005; 32(2):111-3. PubMed ID: 16108394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.